CAS RN 152459-95-5
Imatinib, TRC
CAS: 152459-95-5 Molekylformel: C29 H31 N7 O Molekylvikt (g/mol): 493.6 Synonym: Benzamide, 4-[(4-methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-,4-[(4-Methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]benzamide,4-(4-Methylpiperazin-1-ylmethyl)-N-[4-methyl-3-[[4-(pyridin-3-yl)pyrimidin-2-yl]amino]phenyl]benzamide,CGP 57148,Genfatinib,Imatinib IUPAC-namn: 4-[(4-metylpiperazin-1-yl)metyl]-N-[4-metyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]fenyl]bensamid LEDER: CN1CCN(Cc2ccc(cc2)C(=O)Nc3ccc(C)c(Nc4nccc(n4)c5cccnc5)c3)CC1
Imatinib, Mikromol™
Discover Mikromol – din pålitliga källa för högkvalitativa läkemedelsreferensstandarder. Stöder noggrann, regelrätt analys med material som är ackrediterat 17034 ISO och utformat för att säkerställa förtroende för varje resultat.
Imatinib, MedChemExpress
MedChemExpress Imatinib (STI571) is an orally bioavailable tyrosine kinases inhibitor that selectively inhibits BCR/ABL, v-Abl, PDGFR and c-kit kinase activity. Imatinib (STI571) works by binding close to the ATP binding site, locking it in a closed or self-inhibited conformation, therefore inhibiting the enzyme activity of the protein semicompetitively. Imatinib also is an inhibitor of SARS-CoV and MERS-CoV.